Search Results - David Nutt

David Nutt

David John Nutt (born 16 April 1951) is an English neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. He is the chairman of Drug Science, a non-profit which he founded in 2010 to provide independent, evidence-based information on drugs. In 2019 he co-founded the company GABAlabs and its subsidiary SENTIA Spirits which research and market alternatives to alcohol. Until 2009, he was a professor at the University of Bristol heading their Psychopharmacology Unit. Since then he has been the Edmond J Safra chair in Neuropsychopharmacology at Imperial College London and director of the Neuropsychopharmacology Unit in the Division of Brain Sciences there. Nutt was a member of the Committee on Safety of Medicines, and was President of the European College of Neuropsychopharmacology. Provided by Wikipedia
  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Cover Image

    Predicting Responses to Psychedelics: A Prospective Study by Eline C. H. M. Haijen, Mendel Kaelen, Leor Roseman, Leor Roseman, Christopher Timmermann, Christopher Timmermann, Hannes Kettner, Suzanne Russ, David Nutt, Richard E. Daws, Adam D. G. Hampshire, Romy Lorenz, Robin L. Carhart-Harris

    Published 2018
    Connect to this object online.
    Book

    Save to List
    Saved in:
  2. 2
    Cover Image

    Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression by Roberta Murphy, Roberta Murphy, Hannes Kettner, Rick Zeifman, Rick Zeifman, Bruna Giribaldi, Laura Kartner, Jonny Martell, Jonny Martell, Tim Read, Ashleigh Murphy-Beiner, Ashleigh Murphy-Beiner, Michelle Baker-Jones, David Nutt, David Erritzoe, Rosalind Watts, Robin Carhart-Harris, Robin Carhart-Harris

    Published 2022
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: